Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients
Open Access
- 7 January 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (1) , 116
Abstract
Glaucoma is one of the leading causes of permanent vision loss worldwide and has a profound impact on patients’ quality of life. Vision impairment is strongly associated with several psychiatric disorders, like depression, anxiety, and sleep problems. These psychiatric issues are often exacerbated by the gradual, irreversible, and typically silent progression of the disease, contributing to increased mental health challenges for affected individuals. A systematic review was conducted following PRISMA guidelines across six different databases (CINAHL, MEDLINE, PsycINFO, Web of Science, Scopus, and the Cochrane Library) and one gray literature source (Google Scholar), covering the period from 2013 to 2024. Twenty-nine studies involving a total of 13,326,845 subjects were included in the synthesis, highlighting a considerable prevalence of psychiatric disorders among glaucoma patients. Depression and anxiety were the most common conditions identified, with depression rates ranging from 6.6% to 57% and anxiety from 12.11% to 49%. Other less frequent but still significant conditions like sleep disorders, psychosis, dementia, and post-traumatic stress disorder were also observed. The findings also indicated that psychiatric severity was influenced by socio-demographic factors, glaucoma severity, and treatment duration. Given the high occurrence of psychiatric pathologies among individuals with glaucoma, it is essential to develop comprehensive care strategies that address both eye and mental health needs. Multidisciplinary collaboration among ophthalmologists, psychiatrists, psychologists, and primary care physicians is crucial for developing personalized treatment plans that effectively manage both the ocular and psychological aspects of the disease.Keywords
This publication has 55 references indexed in Scilit:
- Interactions of antidepressants with concomitant medications—safety of complex therapies in multimorbiditiesPharmacological Reports, 2024
- The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system modelJournal of Affective Disorders, 2024
- Anxiety, depression, and sleep-related outcomes of glaucoma patients: systematic review and meta-analysisCanadian Journal of Ophthalmology, 2022
- Association Between Visual Impairment and Depression in Patients Attending Eye ClinicsJAMA Ophthalmology, 2021
- Etiologies and clinical characteristics of young patients with angle-closure glaucoma: a 15-year single-center retrospective studyGraefe's Archive for Clinical and Experimental Ophthalmology, 2021
- Validation of the 7-item Generalized Anxiety Disorder scale (GAD-7) as a screening tool for anxiety among pregnant Chinese womenJournal of Affective Disorders, 2021
- Glaucoma in Adults—Screening, Diagnosis, and ManagementJAMA, 2021
- Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A reviewResearch Synthesis Methods, 2020
- Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patientsSupportive Care in Cancer, 2019
- Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicineEPMA Journal, 2018